Market Overview

Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Cash

Share:
Related ILMN
3 Biotech Stocks Bucking Short Interest Trends
Is It Closing Time At The Biotech Bar?
Related
GlaxoSmithKline Will Pay $14.25/Share to Remaining Human Genome Sciences Holders
Benzinga Market Primer, Friday July 27

Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash.

Illumina (NASDAQ: ILMN) had $1.27 billion in total cash and $815.97 million in total debt for the latest quarter.

Onyx Pharmaceuticals (NASDAQ: ONXX) had $599.99 million in total cash and $165.64 million in total debt for the latest quarter.

Human Genome Sciences (NASDAQ: HGSI) had $471.80 million in total cash and $821.50 million in total debt for the latest quarter.

VIVUS (NASDAQ: VVUS) had $333.40 million in total cash and no debt for the latest quarter.

Posted-In: Biotechnology Industry highest cash Mid-CapTrading Ideas

 

Related Articles (HGSI + ILMN)

Around the Web, We're Loving...